Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Solana Name Service (FIDA) vs Hive (HIVE) Price & Performance

Solana Name ServiceTrade

Price performance (Past 24H)

Key statistics

Solana Name Service vs Hive — how do they compare? Solana Name Service trades at Rp311.84 (market cap Rp309,59M, Rp85,45M 24h volume), while Hive trades at Rp707.28 (market cap Rp405,63M, Rp13,91M 24h volume). The key difference: Hive is the larger of the two by market cap, and Solana Name Service's circulating supply is 990,9M FIDA versus 574,6M HIVE for Hive. Which is the better fit depends on your goals — on Pluang, investors hold Solana Name Service for 34 Days and Hive for 42 Days on average.

FIDAHIVE
Market Cap
Rp309,59MRp405,63M
Volume (24h)
Rp85,45MRp13,91M
Circulating Supply
990,9M FIDA574,6M HIVE
Typical Hold Time
34 Days42 Days

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FIDA

No sentiment data available yet.

HIVE
45% Buy55% Sell
Avg holding period · 42 Days

Top news

Latest headlines on both assets

About Solana Name Service

Bonfida is known as a leading infrastructure developer on Solana. They have earned this reputation through their contributions to the ecosystem, providing services and products that support its growth. Some of their contributions include creating the Asset Agnostic Orderbook (AOB) as a new Serum Core engine, simplifying transactions with Solana Name Service, and introducing the first perpetual swap on Solana called Audaces. As a result, their developers are highly respected within the Solana ecosystem.

Read more on FIDA

About Hive

HIVE is a decentralized information sharing network with an accompanying blockchain-based financial ledger built on the Delegated Proof of Stake (DPoS) protocol. Hive is developed to store vast amounts of content and to make it available for time-based monetization. Examples of use include social media with monetized rewards for content producers, interactive games, identity management, polling systems, and micro-loans.

Read more on HIVE